Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential
Claudia A. Costa, Rayssa de Mello Lopes, Letícia S. Ferraz, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 11, pp. 115511-115511
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry
Pratibha Yadav, Kamal Shah
Bioorganic Chemistry (2021) Vol. 109, pp. 104639-104639
Closed Access | Times Cited: 165
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104510-104510
Closed Access | Times Cited: 82
A review: Structure-activity relationship and antibacterial activities of Quinoline based hybrids
Kajalben B. Patel, Premlata Kumari
Journal of Molecular Structure (2022) Vol. 1268, pp. 133634-133634
Closed Access | Times Cited: 41
Recent developments in antimalarial activities of 4-aminoquinoline derivatives
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115458-115458
Closed Access | Times Cited: 27
Recent advances in functionalized quinoline scaffolds and hybrids—Exceptional pharmacophore in therapeutic medicine
Oluwadunni F. Elebiju, Olayinka O. Ajani, Gbolahan O. Oduselu, et al.
Frontiers in Chemistry (2023) Vol. 10
Open Access | Times Cited: 26
Synthesis, anticancer activity and molecular docking of new quinolines, quinazolines and 1,2,4-triazoles with pyrido[2,3-d] pyrimidines
Ameen A. Abu‐Hashem, Othman Hakami, Nasser Amri
Heliyon (2024) Vol. 10, Iss. 5, pp. e26735-e26735
Open Access | Times Cited: 11
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115609-115609
Closed Access | Times Cited: 15
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Recent Advances in the Synthesis of Fused‐Cyclic Quinolines
Shahab A. Darbandizadeh, Saeed Balalaie
Asian Journal of Organic Chemistry (2024) Vol. 13, Iss. 5
Closed Access | Times Cited: 4
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113606-113606
Closed Access | Times Cited: 31
Design, synthesis, in silico, and pharmacological evaluation of novel quinoline derivatives containing substituted piperazine moieties as potential anti-breast cancer agents
M. Gnana Ruba Priya, V. Raja Solomon, Nagarajan Hemavathy, et al.
Results in Chemistry (2024) Vol. 7, pp. 101359-101359
Open Access | Times Cited: 4
An ecofriendly and reusable catalyst RuO2/MWCNT in the green synthesis of sulfonyl-quinolines
Singamsetty Harikrishna, Kranthi Kumar Gangu, Alice R. Robert, et al.
Process Safety and Environmental Protection (2022) Vol. 159, pp. 911-917
Closed Access | Times Cited: 19
Synthesis, cytotoxicity, docking, MD simulation, drug-likeness, ADMET prediction and multi spectroscopic studies of some novel quinoline-4-carboxamide derivatives as DNA intercalating and anticancer agents
Negar Omidkhah, Jamshidkhan Chamani, Farzaneh Fatemi, et al.
Journal of Molecular Structure (2024) Vol. 1322, pp. 140334-140334
Closed Access | Times Cited: 3
Potential therapeutic targets shared between leishmaniasis and cancer
Sajad Rashidi, Celia Fernández-Rubio, Raúl Manzano-Román, et al.
Parasitology (2021) Vol. 148, Iss. 6, pp. 655-671
Open Access | Times Cited: 23
Synthesis, design, and antimicrobial activity of pyrido[2,3‐d][1,2,4]triazolo[4,3‐a]pyrimidinones based on quinoline derivatives
Ameen A. Abu‐Hashem, Mahmoud N. M. Yousif, Abdel-Rahman B.A. El-Gazzar, et al.
Journal of the Chinese Chemical Society (2023) Vol. 70, Iss. 12, pp. 2187-2205
Closed Access | Times Cited: 9
Gold‐Catalyzed Annulation of Ynamides with Aminocarbonyls as a Route to 2‐Aminoquinolines Diversely Substituted at the 4th‐Position
Nikolay V. Shcherbakov, Polina F. Kotikova, Elena I. Chikunova, et al.
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 14, pp. 2428-2434
Closed Access | Times Cited: 7
Synthesis, spectroscopic characterization, DFT, molecular docking and in vitro antibacterial potential of novel quinoline derivatives
Younos Bouzian, Yusuf Sert, Khalid Karrouchi, et al.
Journal of Molecular Structure (2021) Vol. 1246, pp. 131217-131217
Open Access | Times Cited: 18
Recent Advances in Ester Synthesis by Multi-Component Reactions (MCRs): A Review
Dhaval B. Patel, Jagruti A. Parmar, Siddharth S. Patel, et al.
Current Organic Chemistry (2021) Vol. 25, Iss. 5, pp. 539-553
Closed Access | Times Cited: 17
Design, Synthesis, and Biological Studies of C-5-Substituted Diazenyl Derivatives of Uracil as Potent and Selective Antileishmanial Agents Targeting Uridine Biosynthesis Pathway Enzymes
Tushar Das, Prakash Kumar, Sachin Kumar, et al.
ACS Infectious Diseases (2024)
Closed Access | Times Cited: 1
Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones
Ameen A. Abu‐Hashem, Sami A. Al‐Hussain
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1632-1632
Open Access | Times Cited: 1
Synthesis, SAR study, and bioactivity evaluation of a series of Quinoline-Indole-Schiff base derivatives: Compound 10E as a new Nur77 exporter and autophagic death inducer
Baicun Li, Jie Yao, Fengming He, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 105008-105008
Closed Access | Times Cited: 11
Thais savignyi tissue extract: bioactivity, chemical composition, and molecular docking
Mohamed R. Habib, Ahmed A. Hamed, Rasha E. M. Ali, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 1899-1914
Open Access | Times Cited: 7
Novel phenanthridine amide analogs as potential anti-leishmanial agents: In vitro and in silico insights
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105414-105414
Closed Access | Times Cited: 9
Lewis Acid Catalyzed [4 + 2] Annulation of Propargylic Alcohols with 2-Vinylanilines
Xi-Yan Ren, Xiang‐Xuan Feng, Hong‐Yu Zhang, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 22, pp. 16007-16017
Closed Access | Times Cited: 3
Cysteine proteases as potential targets for anti-trypanosomatid drug discovery
Wagner Alves de Souza Júdice, Letícia S. Ferraz, Rayssa de Mello Lopes, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116365-116365
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top